Literature DB >> 12480282

Enhanced transport of a novel anti-HIV agent--cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers.

Chandrasekhar Udata1, Jignesh Patel, Dhananjay Pal, Elzbieta Hejchman, Mark Cushman, Ashim K Mitra.   

Abstract

PURPOSE: Cosalane is a potent inhibitor of HIV replication with activity against a broad range of viral targets. However, oral bioavailability of this highly lipophilic compound is extremely poor (<1%). The purpose of this study is to screen a variety of permeation enhancers (cyclodextrin derivatives, cremophor EL, bile salts and mixed micelles) for their ability to enhance the transport of cosalane and its analogs/prodrugs across Caco-2 cell monolayers.
METHODS: Cosalane and its different analogs/prodrugs were synthesized and their physicochemical properties were determined. Caco-2 cells were cultured at a density of 66,000 cells/cm(2) either on collagen coated clear polyester membranes or Transwell inserts. Side-bi-side diffusion cells and Transwell inserts were employed to study for the transport of cosalane and its analogs/prodrugs with various permeation enhancers across Caco-2 cell monolayers.
RESULTS: Permeabilities of EH-3-39, EH-3-55 and EH-3-57 significantly improved compared to that of cosalane in the presence of bile salt, sodium desoxycholate. Among the various cyclodextrins studied, hydroxypropyl beta cyclodextrin (HP-beta-CD) and dimethyl beta cyclodextrin (DM-beta-CD) exhibited 22.3-fold and 19-fold permeability enhancement of cosalane respectively across Caco-2 cell monolayers. Sodium desoxycholate (10 mM) also showed a remarkable (105-fold) enhancement on the permeability of cosalane (P(app) 11.72+/-3.31 x 10(-6) cm/s) without causing any measurable cellular damage. Cremophor EL resulted in higher transport of 14C mannitol. The mechanism of enhancement effect can be mainly attributed to the alteration of membrane fluidity by cyclodextrin and opening of tight junctions by cremophor EL.
CONCLUSIONS: Among the enhancers tested, 10 mM sodium desoxycholate and HP-beta-CD appear to be viable candidates for further development of an oral formulation of cosalane and its congeners.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12480282     DOI: 10.1016/s0378-5173(02)00523-9

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Preparation, characterization, and in vitro intestinal permeability evaluation of thalidomide-hydroxypropyl-β-cyclodextrin complexes.

Authors:  Jadel M Kratz; Marina R Teixeira; Karine Ferronato; Helder F Teixeira; Letícia S Koester; Cláudia M O Simões
Journal:  AAPS PharmSciTech       Date:  2011-12-09       Impact factor: 3.246

2.  Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovir.

Authors:  Ravi S Talluri; Swapan K Samanta; Ripal Gaudana; Ashim K Mitra
Journal:  Int J Pharm       Date:  2008-06-23       Impact factor: 5.875

3.  Improving tenoxicam solubility and bioavailability by cosolvent system.

Authors:  Ming-Kung Yeh; Li-Chien Chang; Andy Hong-Jey Chiou
Journal:  AAPS PharmSciTech       Date:  2009-02-18       Impact factor: 3.246

4.  A Potent, Broad-Spectrum Antiviral Agent that Targets Viral Membranes.

Authors:  Jason A Wojcechowskyj; Robert W Doms
Journal:  Viruses       Date:  2010-05-04       Impact factor: 5.818

5.  A novel 5-Fluorocuracil multiple-nanoemulsion used for the enhancement of oral bioavailability in the treatment of colorectal cancer.

Authors:  Niyaz Ahmad; Ahmed A Albassam; Mohd Faiyaz Khan; Zabih Ullah; Taysser Mohammed Buheazah; Hussain Salman AlHomoud; Hassan Ali Al-Nasif
Journal:  Saudi J Biol Sci       Date:  2022-03-14       Impact factor: 4.052

6.  Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation.

Authors:  Rudra Pangeni; Sang Won Choi; Ok-Cheol Jeon; Youngro Byun; Jin Woo Park
Journal:  Int J Nanomedicine       Date:  2016-11-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.